Publicaciones en colaboración con investigadores/as de Universidad de Sevilla (13)

2024

  1. Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

2023

  1. Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: A nationwide proficiency study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 335-341

  2. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435

2021

  1. Reporting antimicrobial susceptibilities and resistance phenotypes in Staphylococcus spp.: a nationwide proficiency study

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 5, pp. 1187-1196

2016

  1. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain

    Journal of Infection, Vol. 72, Núm. 2, pp. 152-160

2015

  1. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 9, pp. 625.e1-625.e23

  2. Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 9, pp. 626-632

2014

  1. Inhibitor-resistant TEM- And OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 7, pp. 3874-3881

2013

  1. Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli

    Journal of Clinical Microbiology, Vol. 51, Núm. 7, pp. 2414-2417

2012

  1. Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3576-3581

2011

  1. Programs to optimize antimicrobial use (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document

    Medicina Preventiva, Vol. 17, Núm. 3, pp. 29-39

2009

  1. Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en hospitales españoles: Segundo estudio multicéntrico (proyecto GEIH-BLEE 2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 9, pp. 503-510

2005

  1. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 2122-2125